annual D&A:
$56.67M+$2.62M(+4.84%)Summary
- As of today (June 22, 2025), ALNY annual depreciation & amortization is $56.67 million, with the most recent change of +$2.62 million (+4.84%) on December 31, 2024.
- During the last 3 years, ALNY annual D&A has fallen by -$33.02 million (-36.82%).
- ALNY annual D&A is now -36.82% below its all-time high of $89.69 million, reached on December 31, 2021.
Performance
ALNY Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$14.40M+$34.95M(+170.11%)Summary
- As of today (June 22, 2025), ALNY quarterly depreciation & amortization is $14.40 million, with the most recent change of +$34.95 million (+170.11%) on March 31, 2025.
- Over the past year, ALNY quarterly D&A has increased by +$888.00 thousand (+6.57%).
- ALNY quarterly D&A is now -60.71% below its all-time high of $36.66 million, reached on June 30, 2024.
Performance
ALNY quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$57.56M+$888.00K(+1.57%)Summary
- As of today (June 22, 2025), ALNY TTM depreciation & amortization is $57.56 million, with the most recent change of +$888.00 thousand (+1.57%) on March 31, 2025.
- Over the past year, ALNY TTM D&A has increased by +$16.07 million (+38.72%).
- ALNY TTM D&A is now -40.58% below its all-time high of $96.87 million, reached on March 31, 2022.
Performance
ALNY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ALNY Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | +6.6% | +38.7% |
| 3 y3 years | -36.8% | -27.2% | -40.6% |
| 5 y5 years | +4.2% | -15.3% | +0.5% |
ALNY Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.8% | +27.4% | -60.7% | +170.1% | -40.6% | +38.7% |
| 5 y | 5-year | -36.8% | +27.4% | -60.7% | +170.1% | -40.6% | +38.7% |
| alltime | all time | -36.8% | >+9999.0% | -60.7% | +170.1% | -40.6% | >+9999.0% |
ALNY Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $14.40M(-170.1%) | $57.56M(+1.6%) |
| Dec 2024 | $56.67M(+4.8%) | -$20.55M(-176.0%) | $56.67M(-2.6%) |
| Sep 2024 | - | $27.04M(-26.2%) | $58.21M(+6.4%) |
| Jun 2024 | - | $36.66M(+171.2%) | $54.71M(+31.8%) |
| Mar 2024 | - | $13.52M(-171.1%) | $41.49M(-23.2%) |
| Dec 2023 | $54.05M(+21.6%) | -$19.00M(-180.8%) | $54.05M(-4.9%) |
| Sep 2023 | - | $23.53M(+0.4%) | $56.86M(+5.3%) |
| Jun 2023 | - | $23.45M(-10.1%) | $53.98M(+6.3%) |
| Mar 2023 | - | $26.08M(-261.0%) | $50.77M(+14.2%) |
| Dec 2022 | $44.47M(-50.4%) | -$16.20M(-178.4%) | $44.47M(-45.8%) |
| Sep 2022 | - | $20.65M(+2.0%) | $82.12M(-3.0%) |
| Jun 2022 | - | $20.24M(+2.3%) | $84.69M(-12.6%) |
| Mar 2022 | - | $19.78M(-7.8%) | $96.87M(+8.0%) |
| Dec 2021 | $89.69M(+20.5%) | $21.45M(-7.6%) | $89.69M(+0.6%) |
| Sep 2021 | - | $23.22M(-28.4%) | $89.12M(+5.3%) |
| Jun 2021 | - | $32.42M(+157.3%) | $84.67M(+20.9%) |
| Mar 2021 | - | $12.60M(-39.7%) | $70.03M(-5.9%) |
| Dec 2020 | $74.44M(+36.9%) | $20.88M(+11.2%) | $74.44M(+9.0%) |
| Sep 2020 | - | $18.77M(+5.6%) | $68.32M(+8.7%) |
| Jun 2020 | - | $17.78M(+4.5%) | $62.87M(+9.8%) |
| Mar 2020 | - | $17.01M(+15.2%) | $57.28M(+5.4%) |
| Dec 2019 | $54.37M(+256.6%) | $14.76M(+10.8%) | $54.37M(+10.9%) |
| Sep 2019 | - | $13.33M(+9.4%) | $49.03M(+35.8%) |
| Jun 2019 | - | $12.19M(-13.5%) | $36.11M(+38.0%) |
| Mar 2019 | - | $14.09M(+49.5%) | $26.16M(+71.6%) |
| Dec 2018 | $15.25M(+28.2%) | $9.43M(+2227.4%) | $15.25M(+89.0%) |
| Sep 2018 | - | $405.00K(-81.9%) | $8.07M(-28.3%) |
| Jun 2018 | - | $2.24M(-29.5%) | $11.25M(-6.8%) |
| Mar 2018 | - | $3.18M(+41.6%) | $12.08M(+1.5%) |
| Dec 2017 | $11.90M(-21.4%) | $2.25M(-37.4%) | $11.90M(-6.1%) |
| Sep 2017 | - | $3.59M(+17.0%) | $12.67M(+0.7%) |
| Jun 2017 | - | $3.07M(+2.2%) | $12.58M(-7.0%) |
| Mar 2017 | - | $3.00M(-0.6%) | $13.53M(-10.6%) |
| Dec 2016 | $15.13M(-20.6%) | $3.02M(-13.8%) | $15.13M(-11.9%) |
| Sep 2016 | - | $3.50M(-12.7%) | $17.18M(-9.3%) |
| Jun 2016 | - | $4.01M(-12.8%) | $18.95M(-5.1%) |
| Mar 2016 | - | $4.60M(-9.2%) | $19.96M(+4.8%) |
| Dec 2015 | $19.05M(+59.7%) | $5.07M(-3.8%) | $19.05M(+10.0%) |
| Sep 2015 | - | $5.27M(+5.0%) | $17.32M(+14.2%) |
| Jun 2015 | - | $5.02M(+36.1%) | $15.17M(+16.5%) |
| Mar 2015 | - | $3.69M(+10.4%) | $13.02M(+9.1%) |
| Dec 2014 | $11.93M | $3.34M(+7.2%) | $11.93M(+6.4%) |
| Sep 2014 | - | $3.12M(+8.7%) | $11.21M(+3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $2.87M(+10.3%) | $10.86M(+1.5%) |
| Mar 2014 | - | $2.60M(-1.0%) | $10.70M(+4.6%) |
| Dec 2013 | $10.23M(+13.2%) | $2.63M(-5.0%) | $10.23M(+6.3%) |
| Sep 2013 | - | $2.76M(+2.0%) | $9.63M(+5.2%) |
| Jun 2013 | - | $2.71M(+27.5%) | $9.15M(+1.2%) |
| Mar 2013 | - | $2.13M(+5.1%) | $9.04M(+0.1%) |
| Dec 2012 | $9.04M(+76.3%) | $2.02M(-11.4%) | $9.04M(+9.5%) |
| Sep 2012 | - | $2.29M(-12.3%) | $8.25M(+14.2%) |
| Jun 2012 | - | $2.60M(+22.8%) | $7.22M(+22.3%) |
| Mar 2012 | - | $2.12M(+71.5%) | $5.91M(+15.3%) |
| Dec 2011 | $5.13M(+3.7%) | $1.24M(-2.0%) | $5.13M(-1.0%) |
| Sep 2011 | - | $1.26M(-1.9%) | $5.18M(-0.1%) |
| Jun 2011 | - | $1.29M(-3.9%) | $5.18M(+1.3%) |
| Mar 2011 | - | $1.34M(+3.7%) | $5.12M(+3.6%) |
| Dec 2010 | $4.94M(-17.5%) | $1.29M(+2.0%) | $4.94M(+3.2%) |
| Sep 2010 | - | $1.27M(+3.5%) | $4.79M(+3.3%) |
| Jun 2010 | - | $1.22M(+5.3%) | $4.63M(-13.5%) |
| Mar 2010 | - | $1.16M(+2.2%) | $5.35M(-10.7%) |
| Dec 2009 | $5.99M(+4.6%) | $1.14M(+2.3%) | $5.99M(-9.9%) |
| Sep 2009 | - | $1.11M(-42.8%) | $6.65M(-7.2%) |
| Jun 2009 | - | $1.94M(+7.8%) | $7.17M(+9.1%) |
| Mar 2009 | - | $1.80M(+0.2%) | $6.58M(+14.9%) |
| Dec 2008 | $5.73M(+40.3%) | $1.80M(+10.2%) | $5.73M(+18.6%) |
| Sep 2008 | - | $1.63M(+21.2%) | $4.83M(+13.7%) |
| Jun 2008 | - | $1.35M(+41.5%) | $4.25M(+10.7%) |
| Mar 2008 | - | $951.00K(+5.4%) | $3.84M(-6.0%) |
| Dec 2007 | $4.08M(+7.0%) | $902.00K(-13.9%) | $4.08M(-4.3%) |
| Sep 2007 | - | $1.05M(+11.8%) | $4.27M(-15.8%) |
| Jun 2007 | - | $937.00K(-21.6%) | $5.07M(+20.1%) |
| Mar 2007 | - | $1.20M(+9.9%) | $4.22M(+10.6%) |
| Dec 2006 | $3.81M(+22.3%) | $1.09M(-41.3%) | $3.81M(+9.6%) |
| Sep 2006 | - | $1.85M(+2003.4%) | $3.48M(+46.9%) |
| Jun 2006 | - | $88.00K(-88.8%) | $2.37M(-26.7%) |
| Mar 2006 | - | $789.00K(+4.9%) | $3.23M(+3.7%) |
| Dec 2005 | $3.12M(+27.6%) | $752.00K(+1.6%) | $3.12M(+0.0%) |
| Sep 2005 | - | $740.00K(-22.3%) | $3.12M(+0.4%) |
| Jun 2005 | - | $952.00K(+41.0%) | $3.11M(+19.1%) |
| Mar 2005 | - | $675.00K(-10.1%) | $2.61M(+6.7%) |
| Dec 2004 | $2.44M(+191.6%) | $751.00K(+3.2%) | $2.44M(+44.4%) |
| Sep 2004 | - | $728.00K(+60.4%) | $1.69M(+75.4%) |
| Jun 2004 | - | $454.00K(-11.2%) | $965.00K(+88.8%) |
| Mar 2004 | - | $511.00K | $511.00K |
| Dec 2003 | $838.00K(+2227.8%) | - | - |
| Dec 2002 | $36.00K | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual D&A year-on-year change?
- What is Alnylam Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly D&A year-on-year change?
- What is Alnylam Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM D&A year-on-year change?
What is Alnylam Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ALNY is $56.67M
What is the all time high annual D&A for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual depreciation & amortization is $89.69M
What is Alnylam Pharmaceuticals annual D&A year-on-year change?
Over the past year, ALNY annual depreciation & amortization has changed by +$2.62M (+4.84%)
What is Alnylam Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ALNY is $14.40M
What is the all time high quarterly D&A for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly depreciation & amortization is $36.66M
What is Alnylam Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ALNY quarterly depreciation & amortization has changed by +$888.00K (+6.57%)
What is Alnylam Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ALNY is $57.56M
What is the all time high TTM D&A for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM depreciation & amortization is $96.87M
What is Alnylam Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ALNY TTM depreciation & amortization has changed by +$16.07M (+38.72%)